Table 3.
GOLDN study (n=782)
|
MESA study (n=2035)
|
Meta-analysisa
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Difference in BMI |
Difference in BMI |
Difference in BMI |
||||||||
β coefficient | SE | P for interactionb | β coefficient | SE | P for interactionc | β coefficient | SE | P for interaction | Q | |
Total fats, % | 0.0127 | 0.0046 | 0.010 | 0.0048 | 0.0024 | 0.046 | 0.0065 | 0.0057 | 0.002 | 0.128 |
SFAs, % | 0.0325 | 0.0108 | 0.005 | 0.0126 | 0.0053 | 0.018 | 0.0165 | 0.0047 | <0.001 | 0.098 |
MUFAs, % | 0.0279 | 0.0120 | 0.021 | 0.0117 | 0.0059 | 0.047 | 0.0149 | 0.0053 | 0.005 | 0.226 |
PUFAs, % | 0.0179 | 0.0136 | 0.194 | 0.0020 | 0.0100 | 0.845 | 0.0076 | 0.0081 | 0.347 | 0.346 |
Abbreviations: BMI, body mass index; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.
Estimated from the combined analyses using a weighted inverse normal method via the function “metagen”, with a fixed effect, using META R package; Q = Cochran‘s Q statistic.
Multivariate interaction model using SAS GENMOD procedure adjusted by familial relationships, gender, age, center, tobacco smoking (current vs. former/never), alcohol consumption (current vs. former/never), hyperlipidemia medication use, presence of diabetes, physical activity score and total energy intake.
General linear regression model adjusted by population structure, gender, age, center, tobacco smoking (current vs. former/never), alcohol consumption (current vs. former/never), hyperlipidemia medication use, presence of diabetes, physical activity and total energy intake.